| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 03/01/2001 | DE19936789A1 Neue Pyrrolidinole und ihre Verwendung für die Tumortherapie New Pyrrolidinole and their use for tumor therapy |
| 03/01/2001 | CA2384511A1 Substituted chiral allosteric hemoglobin modifiers |
| 03/01/2001 | CA2382311A1 Substituted piperazine derivatives, the preparation thereof and their use as medicaments |
| 03/01/2001 | CA2381096A1 Compounds that inhibit tryptase activity |
| 03/01/2001 | CA2376509A1 Process and intermediates for the preparation of isoxazolecaroxamides and analogues |
| 03/01/2001 | CA2376452A1 Synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates |
| 02/28/2001 | EP1077978A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 02/28/2001 | EP1077951A1 N,n'-azobis-nitroazoles and analogs thereof as igniter compounds for use in energetic compositions |
| 02/28/2001 | EP1077941A1 Compounds with growth hormone releasing properties |
| 02/28/2001 | EP1077938A1 2-(2-methylphenyl)-3,4-dihydro-2h-pyrrol derivatives |
| 02/28/2001 | EP1077931A1 Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 02/28/2001 | EP1077928A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/28/2001 | EP1077927A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/28/2001 | EP0555483B1 Process for producing azacycloalkane derivative |
| 02/28/2001 | EP0429611B1 Aminoalkyl maleimides and haptene and antigen derivatives thereof and conjugates with peptides or proteins |
| 02/28/2001 | CN1285347A Technology for recovery of N-methyepyrrolidone from treatment of lithium cell industrial waste gas |
| 02/27/2001 | US6194413 Hemoregulatory compounds |
| 02/22/2001 | WO2001012699A1 Electrically conductive polymers capable of being covalently grafted on by light, method for obtaining same and uses as supports in probes for specific identification in electronic biosensors |
| 02/22/2001 | WO2001012622A1 Piperidine and pyrrolidine derivatives displaying neuronal activity |
| 02/22/2001 | WO2001012587A1 Aminosalicylclic acid amides and their use for combating organisms that are harmful to plants |
| 02/22/2001 | WO2001012186A1 Cell adhesion inhibitors |
| 02/22/2001 | WO2000071514A8 α-AMINO-β-SULFONYL HYDROXAMIC ACID COMPOUNDS |
| 02/22/2001 | WO2000055126A3 N-cyanomethylamides as protease inhibitors |
| 02/22/2001 | WO2000032588A3 Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds |
| 02/22/2001 | WO1999063996A8 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 02/22/2001 | DE19939516A1 New 1-carboxyalkyl-4-(hetero)aryl-piperazine derivatives, as microsomal triglyceride transfer protein inhibitors useful for reducing plasma atherogenic lipoprotein levels, e.g. in treatment of hyperlipidemia |
| 02/22/2001 | DE19938737A1 Aminosalicylsäureamide Aminosalicylamides |
| 02/22/2001 | CA2380817A1 Cell adhesion inhibitors |
| 02/21/2001 | EP1076646A1 Method for stereochemically controlled production of isomerically pure highly substituted azacyclic compounds |
| 02/21/2001 | EP1076645A1 Process for the preparation of methyl(2s)-2-[(3r)-3-(n-[tert-butyloxycarbonyl]-amino) -2-oxopyrr olidin-1-yl]propionate |
| 02/21/2001 | CN1285085A Electrochemical cells composite cathodes comprising cationic polymers and electroactive polysulfide compounds |
| 02/20/2001 | US6191284 Ligands and complexes for enantioselective hydrogenation |
| 02/20/2001 | US6191277 Hydroxypropylamide peptidomimetics as inhibitors of aspartyl proteases |
| 02/20/2001 | US6191165 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 02/20/2001 | US6191161 Prolylendopeptidase inhibitors |
| 02/20/2001 | US6191146 Hemoregulatory compounds |
| 02/20/2001 | US6191142 Aroyl aminoacyl pyrroles for use in the treatment of neuropathic pain |
| 02/20/2001 | US6190852 Coupler provides a desirably narrow spectrographic absorption curve. |
| 02/15/2001 | WO2001010894A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 02/15/2001 | WO2001010842A2 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 02/15/2001 | WO2001010839A2 Multivalent substituted ketoamides and amides for treating hair loss |
| 02/15/2001 | WO2001010838A1 Multivalent compounds |
| 02/15/2001 | WO2001010836A1 Method of treating hair loss using multivalent ketoamides and amides |
| 02/15/2001 | WO2001010834A2 Antibacterial agents |
| 02/15/2001 | WO2001010833A1 Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain |
| 02/15/2001 | WO2001010832A1 Pyrrolidine compounds and their use for treating hyperproliferative diseases and tumor diseases |
| 02/15/2001 | WO2001010831A1 Substituted pyrrolidin-2,3,4-trion-3-oxime derivatives useful as nmda-receptor antagonists |
| 02/15/2001 | WO2001010827A1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 02/15/2001 | WO2001010823A1 Carboxylic acid amides, their production and their use as drugs |
| 02/15/2001 | WO2001010799A1 Methods for preparing n-[(aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds |
| 02/15/2001 | WO2001010439A1 Cyclic amine ccr3 antagonists |
| 02/15/2001 | WO2001010429A2 Long chain n-alkyl compounds and oxa-derivatives thereof and use as antiviral compositions |
| 02/15/2001 | WO2001010383A2 Caspase inhibitors and uses thereof |
| 02/15/2001 | DE19936719A1 Substituierte 1,5-Dihydropyrrol-2-on-Derivate Substituted 1,5-dihydropyrrol-2-one derivatives |
| 02/15/2001 | DE19936521A1 Substituierte Pyrrolidin-2,3,4-trion-3-oxim-Derivate Substituted pyrrolidine-2,3,4-trione-3-oxime Derivatives |
| 02/15/2001 | CA2381033A1 Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain |
| 02/15/2001 | CA2381008A1 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 02/15/2001 | CA2380973A1 Substituted pyrrolidine-2-3,4-trione 3-oxime derivatives which are active as nmda receptor antagonists |
| 02/15/2001 | CA2380647A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 02/15/2001 | CA2378499A1 Cyclic amine ccr3 antagonists |
| 02/15/2001 | CA2378310A1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 02/14/2001 | EP1075465A1 Arylphenyl-substituted cyclic keto enols |
| 02/14/2001 | EP1075261A1 Mycobacterial inhibitors |
| 02/14/2001 | CN1284063A Compounds |
| 02/14/2001 | CN1284059A Biphenylamidine derivatives |
| 02/13/2001 | US6187955 Guanidine derivatives and process for their production |
| 02/13/2001 | US6187932 Subjecting n-(d-alpha-methyl-beta-acylthiopropionyl)-l-proline to hydrolysis reaction in aqueous medium in presence of strong acid at specified temperature to remove acyl group, isolating captopril |
| 02/13/2001 | US6187812 For controlling animal pests or harmful fungi; (e,e,e)-2-methoxyimino-2-(2'-(1?-methyl, 1?-(1?'-ethoxyiminoethyl))iminooxymethyl)phenylacetic acid monomethylamide, for example |
| 02/13/2001 | US6187807 Methods of use and compositions of (S) (-)-amisulpride |
| 02/13/2001 | US6187804 2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1 -hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid, salt or hydrolysable ester thereof for example, dry blended with an alkali metal carbonate or bicarbonate |
| 02/13/2001 | US6187799 Inhibition of raf kinase activity using aryl ureas |
| 02/13/2001 | US6187772 Pyrroloazepine compounds |
| 02/13/2001 | CA2203942C A pyrrolidylthiocarbapenem derivative |
| 02/08/2001 | WO2001009169A2 Cysteine protease inhibitors |
| 02/08/2001 | WO2001009110A1 Novel succinate derivative compounds useful as cysteine protease inhibitors |
| 02/08/2001 | WO2001009095A1 Mutilin derivatives and their use as antibacterials |
| 02/08/2001 | WO2001009091A1 Method for producing protected acyl guanidines by way of mukaiyama reaction |
| 02/08/2001 | WO2001009088A1 Urea derivatives as inhibitors of ccr-3 receptor |
| 02/08/2001 | WO2001008685A1 Acyclic and cyclic amine derivatives |
| 02/08/2001 | WO2000066528A3 Quinones for treatment of diseases |
| 02/08/2001 | WO2000061783A3 Process for preparing inhibitors of nucleoside metabolism |
| 02/08/2001 | DE19937494A1 New carboxylic acid amides are Factor Xa and serine protease inhibitors, useful for the treatment and prevention of thrombotic disorders, tumors and fibrin-dependent inflammation |
| 02/08/2001 | CA2380578A1 Ring opened cpis |
| 02/08/2001 | CA2379993A1 Acyclic and cyclic amine derivatives |
| 02/07/2001 | EP1073672A1 Antipicornaviral compounds, their preparation and use |
| 02/07/2001 | EP1073635A1 Substituted pyrrolidine hydroxamate metalloprotease inhibitors |
| 02/07/2001 | EP1073634A1 Method for producing enantiomer-free n-methyl-n- (1s)-1-phenyl- 2-((3s)- 3-hydroxypyrrolidine- 1-yl)ethyl]- 2,2-diphenyl acetamide |
| 02/07/2001 | EP1073633A2 Substituted beta-amino acid inhibitors of methionine aminopeptidase-2 |
| 02/07/2001 | EP1073624A1 Aminomethyl-benzoic ester derivatives as tryptase inhibitors |
| 02/07/2001 | EP1073449A1 Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors |
| 02/07/2001 | EP1073434A1 Ccr-3 receptor antagonists |
| 02/07/2001 | CN1283197A Pleuromutilin derivatives as antimicrobials |
| 02/07/2001 | CN1283185A New crystalline polymorphic form of 1-methyl-5-p-toluoylpyrroel-2-acetamidoacetic acid guaiacyl ester (MED 15) |
| 02/07/2001 | CN1283181A Substituted beta-alanines |
| 02/06/2001 | US6184389 Feature a plurality of functional groups attached to backbone and phosphoramidate sites |
| 02/06/2001 | US6184388 Antibacterial and antimicrobial, quinoline antibiotic |
| 02/06/2001 | US6184249 Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes |
| 02/06/2001 | US6184243 Neurological disorders |
| 02/01/2001 | WO2001007406A1 Novel amide derivatives |
| 02/01/2001 | WO2001007403A1 Naphthyl-substituted sulfonamides |